Candel Therapeutics to Present at November Investor Conferences

What happened

Candel Therapeutics announced that CEO Paul Peter Tak will take part in analyst-led fireside discussions and one-on-one meetings at two investor conferences in November 2026: the Stifel 2026 Healthcare Conference on November 10 and the Jefferies Global Healthcare Conference on November 18.

Confirmed

Global impact / market context

Investor conferences give a small clinical-stage company like Candel a chance to tell its cancer immunotherapy story directly to analysts and fund managers, which can influence how well investors understand the company's experimental treatments and how they value the stock.

Analyst inference

Clinical-stage biotech firms often rely on such appearances to attract investor attention because they have no approved products or product revenue yet, so perceived progress in their immunotherapy programs and management credibility can shape demand for their shares.

Analyst inference

What to watch

1. Candel will hold fireside discussions and one-on-one meetings at the Stifel conference on November 10, 2026, and the Jefferies conference on November 18, 2026. Confirmed
2. The company says live webcasts will be accessible through the Investors section of its website, with replays archived for up to 90 days after each session date. Proposed
3. Comments on the two clinical-stage immunotherapy platforms, which use modified adenovirus and herpes simplex virus constructs to trigger anti-tumor immune responses, may influence investor views on the company's prospects. Analyst inference

Evidence

• globenewswire.com